Pulmonary Disease Doctors in Daly City, CA Accepting Medicare

5 Pulmonary Disease doctors found. Showing 1 - 5

Stephen Park, M.D. Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1900 Sullivan Ave, Daly City, CA 94015 Phone: 650-991-0600    Fax: 650-991-0306

Thomas B Hazlehurst, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1900 Sullivan Ave, Daly City, CA 94015 Phone: 650-400-0277    Fax: 650-340-1785

Raghu Midde, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 901 Campus Dr, Ste 308, Daly City, CA 94015 Phone: 650-991-0600    Fax: 650-991-0306

Thomas Tiffan Bowstead, M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 901 Campus Dr, Ste 308, Daly City, CA 94015 Phone: 650-991-0600    Fax: 650-991-0306

Peter Lu Brion, M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1800 Sullivan Ave, Suite 605, Daly City, CA 94015 Phone: 650-992-8456    Fax: 650-992-8356

News Archive

Study explores the effects of SARS-CoV-2 (and other betacoronaviruses) on cellular mRNA processing

A new study has been released on the bioRxiv* preprint server, which deals with a comprehensive survey on alternative splicing concerning SARS-CoV-2 infection. This study has also included two other betacoronavirurses (SARS-CoV and MERS), a control set of unrelated viruses, and a bacterium, namely, Streptococcus pneumonia. The study findings suggest that several cellular parameters are affected owing to a betacoronavirus infection, which in turn affects some genes and invariably various biological functions.

Optimer submits fidaxomicin rolling NDA for treatment of Clostridium difficile infection

Optimer Pharmaceuticals, Inc. today announced that it has submitted the first section of a rolling New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for fidaxomicin to treat patients with Clostridium difficile infection (CDI) and to prevent recurrences of CDI. Optimer anticipates completing the submission in the fourth quarter of 2010 and plans to request priority review, which, if granted, could lead to an FDA decision on the NDA in the second quarter of 2011.

ImPACKD calls for raising awareness about the risks of calcium overuse in CKD patients

Most Canadians living with CKD have likely never spoken with their physicians about calcium and the serious health risks associated with its overuse. This is why Improving Patient Advocacy in Chronic Kidney Disease (ImPACKD), a group of CKD patients and caregivers committed to raising awareness about the risks of calcium overuse, is starting the conversation about the importance of knowing the limits and keeping them in check.

Chocolate is good for your heart

UCSF scientists are publishing sweet results of a study examining chocolate's effects on blood vessel function in healthy people. The team reports that small daily doses of flavonoid-rich dark chocolate consumed over a two-week period improved blood vessels' ability to dilate, or expand.

Survey: 91% of people around the world believe medical research will result in dementia cure

A new survey from Novartis, Amgen and Banner Alzheimer's Institute, along with Alzheimer's Disease International, shows that 91% of people from around the world believe medical research will result in a treatment for dementia.

Read more Medical News

› Verified 3 days ago